• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析初治 CKD5 患者容量状况与肺动脉高压可能性的关系。

Relationship between volume status and possibility of pulmonary hypertension in dialysis naive CKD5 patients.

机构信息

Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, Kang-won, Korea.

Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Kang-won, Korea.

出版信息

PLoS One. 2019 Sep 3;14(9):e0221970. doi: 10.1371/journal.pone.0221970. eCollection 2019.

DOI:10.1371/journal.pone.0221970
PMID:31479489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6719868/
Abstract

BACKGROUND

Chronic fluid overload is common in patients with chronic kidney disease (CKD) and can with time lead to poor prognosis regarding to the cardiovascular events. Serum NT-proBNP and OH/ECW might reflect fluid status of the patients, and the maximal tricuspid regurgitation velocity (TRVmax) could reflect systolic pulmonary artery pressure (SPAP). We investigated the relationship between markers of volume status and marker of pulmonary hypertension (PH) in non-dialysis CKD5 (CKD5-ND) patients.

METHODS

Bioimpedance spectroscopy (BIS), echocardiography, and measurement of serum NT-proBNP were performed in 137 consecutive patients on the same day. TRVmax greater than or equal to 2.9 m/s, corresponding to SPAP of approximately 36 mmHg, was used as a definition of the possibility of PH in the absence of left heart disease and chronic respiratory disease (PH group).

RESULTS

Patients with possibility of PH (TRVmax ≥ 2.9 m/s) was found in 27 (19.70%) patients. Among the values obtained from BIS, those reflecting the fluid balance (OH, OH/ECW, and E/I ratio) were significantly higher in the PH group. The OH/ECW in patients with PH were significantly higher than those patients without (26.76 ± 15.07 vs. 13.09 ± 15.05, P < 0.001). NT-proBNP was also significantly higher in PH group compared to the non-PH group (median = 10,112 pg/ml, IQR = 30,847 pg/ml vs. median = 1,973 pg/ml, IQR = 7,093 pg/ml, P < 0.001). OH/ECW was positively associated with TRVmax (r = 0.235, P = 0.006). Multivariate logistic regression revealed that increased OH/ECW and serum NT-proBNP were significantly associated with an increased risk of PH.

CONCLUSIONS

A significant number of patients showed increased TRVmax, which was closely related to volume status in CKD5-ND patients. Echocardiography and BIS could be important players in a high possibility of PH detection and treatment in asymptomatic CKD patients. Therefore, these measures could be helpful to improve the cardiac outcomes after initiating renal replacement therapy. Further research may be needed to validate the consistency of this association across other stages of CKD.

摘要

背景

慢性液体超负荷在慢性肾脏病(CKD)患者中很常见,随着时间的推移,这可能导致心血管事件的预后不良。血清 NT-proBNP 和 OH/ECW 可能反映患者的液体状态,而最大三尖瓣反流速度(TRVmax)可反映收缩期肺动脉压(SPAP)。我们研究了非透析 CKD5(CKD5-ND)患者中容量状态标志物与肺动脉高压(PH)标志物之间的关系。

方法

对 137 例连续患者进行生物电阻抗谱(BIS)、超声心动图和血清 NT-proBNP 测量。当无左心疾病和慢性呼吸道疾病时,TRVmax 大于或等于 2.9m/s(对应于约 36mmHg 的 SPAP)被用作 PH 可能性的定义(PH 组)。

结果

发现 27 例(19.70%)患者存在 PH 的可能性(TRVmax≥2.9m/s)。在 BIS 获得的值中,反映液体平衡的那些值(OH、OH/ECW 和 E/I 比值)在 PH 组中明显更高。PH 组的 OH/ECW 明显高于无 PH 组(26.76±15.07 与 13.09±15.05,P<0.001)。PH 组的 NT-proBNP 也明显高于非 PH 组(中位数=10112pg/ml,IQR=30847pg/ml 与中位数=1973pg/ml,IQR=7093pg/ml,P<0.001)。OH/ECW 与 TRVmax 呈正相关(r=0.235,P=0.006)。多变量 logistic 回归显示,OH/ECW 和血清 NT-proBNP 升高与 PH 风险增加显著相关。

结论

相当数量的患者出现了 TRVmax 增加,这与 CKD5-ND 患者的容量状态密切相关。超声心动图和 BIS 可能是无症状 CKD 患者检测和治疗高 PH 可能性的重要手段。因此,这些措施可能有助于改善开始肾脏替代治疗后的心脏结局。可能需要进一步的研究来验证这种关联在 CKD 的其他阶段的一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22d/6719868/d5a30da7e14c/pone.0221970.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22d/6719868/d5a30da7e14c/pone.0221970.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c22d/6719868/d5a30da7e14c/pone.0221970.g001.jpg

相似文献

1
Relationship between volume status and possibility of pulmonary hypertension in dialysis naive CKD5 patients.透析初治 CKD5 患者容量状况与肺动脉高压可能性的关系。
PLoS One. 2019 Sep 3;14(9):e0221970. doi: 10.1371/journal.pone.0221970. eCollection 2019.
2
Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.非透析慢性肾脏病 5 期患者 OH/ECW 与超声心动图参数的相关性研究。
PLoS One. 2018 Apr 9;13(4):e0195202. doi: 10.1371/journal.pone.0195202. eCollection 2018.
3
Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis.液体超负荷是 2 型糖尿病和未透析的 5 期慢性肾脏病导致心脏结构和功能损伤的决定因素。
PLoS One. 2020 Jul 30;15(7):e0235640. doi: 10.1371/journal.pone.0235640. eCollection 2020.
4
Association between E/e´ ratio and fluid overload in patients with predialysis chronic kidney disease.透析前慢性肾脏病患者的E/e´比值与液体超负荷之间的关联。
PLoS One. 2017 Sep 13;12(9):e0184764. doi: 10.1371/journal.pone.0184764. eCollection 2017.
5
Serum leptin level is associated with phase angle in CKD5 patients not undergoing dialysis.血清瘦素水平与未接受透析的 CKD5 患者的相位角相关。
PLoS One. 2018 Aug 8;13(8):e0202055. doi: 10.1371/journal.pone.0202055. eCollection 2018.
6
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.血清N末端脑钠肽作为肺动脉高压患者的预后参数。
Chest. 2006 May;129(5):1313-21. doi: 10.1378/chest.129.5.1313.
7
The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.基质金属蛋白酶在肺动脉高压患者中的作用:一项前瞻性研究的数据。
BMC Cardiovasc Disord. 2021 Dec 20;21(1):607. doi: 10.1186/s12872-021-02424-5.
8
Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis.血浆N末端B型利钠肽原(NT-proBNP)水平作为生物标志物在结节病患者心脏受累及肺动脉高压评估中的意义
Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(1):27-35.
9
Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.维持性血液透析患者中营养不良、N末端B型利钠肽原与心室重构的相互作用
Clin Nephrol. 2013 Apr;79(4):253-60. doi: 10.5414/CN107684.
10
The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.慢性容量超负荷与血液透析患者血压升高之间的关系:生物阻抗法与超声心动图和生物标志物方法相比提供了不同的视角。
Int Urol Nephrol. 2010 Sep;42(3):789-97. doi: 10.1007/s11255-010-9767-y. Epub 2010 Jun 4.

引用本文的文献

1
Clinical influencing factors affecting pulmonary hypertension in hemodialysis patients.影响血液透析患者肺动脉高压的临床影响因素。
Kidney Res Clin Pract. 2025 Jan;44(1):145-154. doi: 10.23876/j.krcp.23.021. Epub 2023 Dec 5.
2
Pulmonary hypertension among maintenance hemodialysis patients in Somalia: a hospital-based observational study.索马里维持性血液透析患者的肺动脉高压:一项基于医院的观察性研究。
Egypt Heart J. 2022 Apr 8;74(1):24. doi: 10.1186/s43044-022-00261-1.
3
The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients.

本文引用的文献

1
Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.非透析慢性肾脏病 5 期患者 OH/ECW 与超声心动图参数的相关性研究。
PLoS One. 2018 Apr 9;13(4):e0195202. doi: 10.1371/journal.pone.0195202. eCollection 2018.
2
Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study.慢性肾脏病合并肺动脉高压患者的流行病学及危险因素:一项回顾性研究
BMC Nephrol. 2018 Mar 20;19(1):70. doi: 10.1186/s12882-018-0866-9.
3
Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
心脏功能对肺动脉高压、其他危险因素的潜在影响及其对透析患者生存的影响。
Int Urol Nephrol. 2021 Feb;53(2):343-351. doi: 10.1007/s11255-020-02655-z. Epub 2021 Jan 3.
4
The Prevalence of Pulmonary Hypertension Among Maintenance Dialysis Patients With ESRD and Its Associated Factors: A Retrospective Study.维持性透析的终末期肾病患者肺动脉高压的患病率及其相关因素:一项回顾性研究
Front Med (Lausanne). 2020 Dec 4;7:570874. doi: 10.3389/fmed.2020.570874. eCollection 2020.
慢性肾脏病和终末期肾病患者的肺动脉高压、死亡率和心血管疾病:系统评价和荟萃分析。
Am J Kidney Dis. 2018 Jul;72(1):75-83. doi: 10.1053/j.ajkd.2017.11.018. Epub 2018 Feb 9.
4
Association between E/e´ ratio and fluid overload in patients with predialysis chronic kidney disease.透析前慢性肾脏病患者的E/e´比值与液体超负荷之间的关联。
PLoS One. 2017 Sep 13;12(9):e0184764. doi: 10.1371/journal.pone.0184764. eCollection 2017.
5
Association of Pulmonary Hypertension With Inflammation and Fluid Overload in Hemodialysis Patients.血液透析患者中肺动脉高压与炎症及液体超负荷的关联
Iran J Kidney Dis. 2017 Jul;11(4):303-308.
6
Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients.肺动脉高压与慢性肾脏病患者的死亡率及心血管事件相关。
Am J Nephrol. 2017;45(2):107-114. doi: 10.1159/000453047. Epub 2016 Dec 10.
7
The Relationship of Fluid Overload as Assessed by Bioelectrical Impedance Analysis with Pulmonary Arterial Hypertension in Hemodialysis Patients.通过生物电阻抗分析评估的液体超负荷与血液透析患者肺动脉高压的关系。
Med Sci Monit. 2016 Feb 14;22:488-94. doi: 10.12659/msm.896305.
8
Association of Pulmonary Hypertension with Mortality in Incident Peritoneal Dialysis Patients.新发病腹膜透析患者肺动脉高压与死亡率的关联
Perit Dial Int. 2015 Sep-Oct;35(5):537-44. doi: 10.3747/pdi.2013.00332. Epub 2014 Sep 2.
9
Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications.肾脏疾病相关肺动脉高压:流行病学、潜在机制及意义。
Am J Nephrol. 2013;37(3):281-90. doi: 10.1159/000348804. Epub 2013 Mar 16.
10
Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial.生物阻抗谱指导下的液体管理对血液透析患者心血管参数的影响:一项随机对照试验。
Am J Kidney Dis. 2013 Jun;61(6):957-65. doi: 10.1053/j.ajkd.2012.12.017. Epub 2013 Feb 15.